High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

September 29, 2020

Study Completion Date

September 27, 2022

Conditions
Multiple MyelomaRenal Failure
Interventions
OTHER

Data collection

Myeloma patients with severe renal impairment who are susceptible to undergo autologous transplantation will be followed in this study, and data related to the pathology, treatments and transplantation will be reported.

Trial Locations (33)

49933

Centre Hospitalier Universitaire d'Angers, Angers

95100

Centre Hospitalier d'Argenteuil, Argenteuil

Unknown

Centre Pierre et Marie Curie, Algiers

EHU Oran, Oran

CHU Sart Tilman, Liège

Centre Hospitalier Universitaire d'Amiens, Amiens

Centre Hospitalier de la Côte Basque, Bayonne

Centre Hospitalier Universitaire de Besançon, Besançon

Centre Hospitalier de Boulogne, Boulogne

CHU de Brest, Brest

Centre Hospitalier de Cholet, Cholet

Centre Hospitalier Universitaire de Clermont Ferrand, Clermont-Ferrand

CHU de Limoges, Limoges

Hôpital Archet, Nice

Hôpital Cochin, Paris

CHU de Rennes, Rennes

Hôpital Victor Provo (Roubaix), Roubaix

Centre Hospitalier de Saint Quentin, Saint-Quentin

Hôpitaux Universitaires de Strasbourg, Strasbourg

American University of Beirut, Beirut

14 000

Centre Hospitalier Universitaire de Caen, Caen

21 079

Centre Hospitalier Universitaire de Dijon, Dijon

38 043

Centre Hospitalier Universitaire de Grenoble, Grenoble

69 373

Centre Léon Bérard, Lyon

34 295

Hôpital Saint-Eloi, Montpellier

54 500

Centre Hospitalier Universitaire de Nancy, Nancy

75 005

Institut Curie, Paris

75 013

Groupe Hospitalier Pitié-Salpétrière, Paris

75 020

Hôpital Saint-Antoine, Paris

Hôpital Tenon, Paris

69 495

Centre Hospitalier Lyon Sud, Pierre-Bénite

86 021

Hôpital Saint-Bernard, Poitiers

42 270

CHU de Saint-Etienne, Saint-Priest-en-Jarez

All Listed Sponsors
collaborator

Institut de Cancérologie de la Loire

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT03234335 - High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment | Biotech Hunter | Biotech Hunter